AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$4.21
-0.01 (-0.24%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+993.8% upside
Low Target
$31.54
Average Target
$46.05
High Target
$64.23
Current Price
$4.21
Current
$4.21
$4.21
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Scenario Analysis
Bear Case
$31.54
649.2%
Low target
Base Case
$46.05
+993.8%
Avg target
Bull Case
$64.23
+1,425.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$6.45
-34.7% from high
52-Week Low
$2.87
+46.7% from low
Target vs 52W High
$46.05
+614.0% vs high
Next Earnings Report
Nov 9, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.43
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals